Coumadin Clinics / When to use 99211 with a protime_What the carriers say

Why This Topic Matters

These services are frequently reviewed by payers because of their volume and the potential for repetitive billing patterns. Understanding the general scope of carrier guidance helps practices reduce denials and maintain documentation that supports the service provided.

Article Sections

1. Overview of carrier concerns

   Introduces the billing topic and explains why Medicare carriers have paid close attention to these visits. It frames the article around anticoagulation monitoring and associated office service reporting.

2. Situations when a separate E/M may be appropriate

   Describes broad scenarios in which an additional evaluation and management service may be considered in connection with anticoagulation monitoring. The section discusses carrier commentary on visit content and documentation expectations.

3. Situations when a separate 99211 would not be payable

   Summarizes examples of routine or non-billable encounters related to prothrombin time testing. It contrasts these with more clearly problem-oriented visits without detailing billing logic.

4. Incident-to and telephone follow-up considerations

   Explains general Medicare supervision and incident-to considerations for these clinic visits. It also notes the treatment of phone-based follow-up in the context of laboratory result review.